| scholarly article | Q13442814 |
| P2093 | author name string | Ao Li | |
| Claudia Turro | |||
| Jeremy J Kodanko | |||
| P2860 | cites work | Ruthenium-decorated lipid vesicles: light-induced release of [Ru(terpy)(bpy)(OH2)]2+ and thermal back coordination. | Q50439618 |
| Dipeptide nitrile inhibitors of cathepsin K. | Q50739284 | ||
| Transition metal complexes with bioactive ligands: mechanisms for selective ligand release and applications for drug delivery. | Q50803523 | ||
| Pivotal Role of a Pentacoordinate (3)MC State on the Photocleavage Efficiency of a Thioether Ligand in Ruthenium(II) Complexes: A Theoretical Mechanistic Study. | Q53791294 | ||
| Ruthenium Polypyridyl Complexes Hopping at Anionic Lipid Bilayers through a Supramolecular Bond Sensitive to Visible Light | Q57342462 | ||
| Esters of 3-pyridylacetic acid that combine potent inhibition of 17 alpha-hydroxylase/C17,20-lyase (cytochrome P45017 alpha) with resistance to esterase hydrolysis | Q71514297 | ||
| Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo | Q73077056 | ||
| Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver | Q77355742 | ||
| Inhibition and induction of cytochrome P450 and the clinical implications | Q77634762 | ||
| Marked differences in light-switch behavior of Ru(II) complexes possessing a tridentate DNA intercalating ligand | Q80474043 | ||
| Ultrafast ligand exchange: detection of a pentacoordinate Ru(II) intermediate and product formation | Q82914288 | ||
| Synthesis, spectroscopic analysis and photolabilization of water-soluble ruthenium(III)-nitrosyl complexes | Q84266726 | ||
| N-acetylmethionine and biotin as photocleavable protective groups for ruthenium polypyridyl complexes | Q84607132 | ||
| Synthetic peptides caged on histidine residues with a bisbipyridyl ruthenium(II) complex that can be photolyzed by visible light | Q86517087 | ||
| Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001 | Q24302773 | ||
| Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore | Q24569706 | ||
| The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders | Q24613957 | ||
| Human steroid biosynthesis for the oncologist | Q26999384 | ||
| Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design | Q27636727 | ||
| Irreversible inhibitors of serine, cysteine, and threonine proteases | Q28217093 | ||
| Structures of human steroidogenic cytochrome P450 17A1 with substrates | Q28249471 | ||
| CYP17 inhibitors for prostate cancer therapy | Q28298818 | ||
| Abiraterone and increased survival in metastatic prostate cancer | Q29617512 | ||
| Unusually efficient pyridine photodissociation from Ru(II) complexes with sterically bulky bidentate ancillary ligands | Q30598699 | ||
| A Ruthenium Nitrosyl That Rapidly Delivers NO to Proteins in Aqueous Solution upon Short Exposure to UV Light | Q30883817 | ||
| Ruthenium(II) bipyridyl complexes as photolabile caging groups for amines | Q31032205 | ||
| Brominated 7-hydroxycoumarin-4-ylmethyls: photolabile protecting groups with biologically useful cross-sections for two photon photolysis | Q31904757 | ||
| A protecting group for carboxylic acids that can be photolyzed by visible light | Q33214847 | ||
| Biologically active molecules with a "light switch". | Q33249214 | ||
| Milestones in the development of photodynamic therapy and fluorescence diagnosis | Q33307700 | ||
| Polychromophoric metal complexes for generating the bioregulatory agent nitric oxide by single- and two-photon excitation | Q33313614 | ||
| RuBi-Glutamate: Two-Photon and Visible-Light Photoactivation of Neurons and Dendritic spines | Q33464333 | ||
| Light activation of a cysteine protease inhibitor: caging of a peptidomimetic nitrile with Ru(II)(bpy)2 | Q33635076 | ||
| Photoexpulsion of surface-grafted ruthenium complexes and subsequent release of cytotoxic cargos to cancer cells from mesoporous silica nanoparticles | Q33862903 | ||
| Inhibition of cathepsin activity in a cell-based assay by a light-activated ruthenium compound | Q33893128 | ||
| [Ru(bpy)2(5-cyanouracil)2]2+ as a potential light-activated dual-action therapeutic agent | Q34006324 | ||
| Odanacatib, a cathepsin K inhibitor for the treatment of osteoporosis and other skeletal disorders associated with excessive bone remodeling. | Q34020306 | ||
| Ruthenium-based chemotherapeutics: are they ready for prime time? | Q34102818 | ||
| Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine. | Q34105908 | ||
| Interindividual variability in inhibition and induction of cytochrome P450 enzymes | Q34192754 | ||
| Photodynamic therapy for cancer | Q34194073 | ||
| Approaching tumour therapy beyond platinum drugs: status of the art and perspectives of ruthenium drug candidates | Q34235515 | ||
| Isolation of a human prostate carcinoma cell line (DU 145) | Q34255312 | ||
| Inhibition and induction of human cytochrome P450 (CYP) enzymes | Q34487744 | ||
| Targeting proteases: successes, failures and future prospects | Q34563752 | ||
| Structure-based development of specific inhibitors for individual cathepsins and their medical applications | Q34598268 | ||
| Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer | Q34768332 | ||
| Control and utilization of ruthenium and rhodium metal complex excited states for photoactivated cancer therapy | Q35128594 | ||
| Photodynamic therapy of cancer: an update | Q35532394 | ||
| Solid-phase synthesis as a platform for the discovery of new ruthenium complexes for efficient release of photocaged ligands with visible light | Q35547191 | ||
| Odanacatib: a review of its potential in the management of osteoporosis in postmenopausal women | Q35589110 | ||
| Photolabile precursors of glutamate: synthesis, photochemical properties, and activation of glutamate receptors on a microsecond time scale | Q35745156 | ||
| Calcium Uncaging with Visible Light. | Q35956041 | ||
| Cysteine cathepsins in human cancer | Q35970409 | ||
| DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity. | Q36514421 | ||
| New Ru(II) complexes for dual photoreactivity: ligand exchange and (1)O2 generation | Q36533554 | ||
| Selective Photodissociation of Acetonitrile Ligands in Ruthenium Polypyridyl Complexes Studied by Density Functional Theory | Q36549488 | ||
| Photoremovable protecting groups in chemistry and biology: reaction mechanisms and efficacy. | Q36570458 | ||
| Cysteine cathepsins: multifunctional enzymes in cancer | Q36600996 | ||
| New Ru(II) Complex for Dual Activity: Photoinduced Ligand Release and (1)O2 Production. | Q36642693 | ||
| Complex reactions catalyzed by cytochrome P450 enzymes | Q36713653 | ||
| Emerging roles of cysteine cathepsins in disease and their potential as drug targets. | Q36740577 | ||
| Versatile photosensitizers for photodynamic therapy at infrared excitation | Q36861117 | ||
| Selective Release of Aromatic Heterocycles from Ruthenium Tris(2-pyridylmethyl)amine with Visible Light | Q36892716 | ||
| Cysteine cathepsins: cellular roadmap to different functions | Q36934250 | ||
| Photorelease of GABA with Visible Light Using an Inorganic Caging Group | Q36936097 | ||
| Molecular pathways: Inhibiting steroid biosynthesis in prostate cancer | Q37076775 | ||
| Effects of Methyl Substitution in Ruthenium Tris(2-pyridylmethyl)amine Photocaging Groups for Nitriles | Q37138342 | ||
| Principles and applications of the photochemical control of cellular processes. | Q37158588 | ||
| Illuminating the chemistry of life: design, synthesis, and applications of "caged" and related photoresponsive compounds. | Q37237208 | ||
| Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis | Q37316559 | ||
| Development of nitrile-based peptidic inhibitors of cysteine cathepsins | Q37694669 | ||
| Ruthenium tris(2-pyridylmethyl)amine as an effective photocaging group for nitriles | Q37714170 | ||
| Combatting AMR: photoactivatable ruthenium(ii)-isoniazid complex exhibits rapid selective antimycobacterial activity. | Q37720315 | ||
| Keys for unlocking photolabile metal-containing cages | Q37829985 | ||
| Light-controlled tools | Q38029303 | ||
| Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals | Q38254225 | ||
| Photoactivated inhibition of cathepsin K in a 3D tumor model | Q38791995 | ||
| A luminescent ruthenium(II) complex for light-triggered drug release and live cell imaging. | Q38845855 | ||
| Strained ruthenium complexes are potent light-activated anticancer agents | Q39354352 | ||
| Ruthenium polypyridyl phototriggers: from beginnings to perspectives | Q39400764 | ||
| A fast ruthenium polypyridine cage complex photoreleases glutamate with visible or IR light in one and two photon regimes. | Q39512704 | ||
| Synthesis, cellular uptake, apopotosis, cytotoxicity, cell cycle arrest, interaction with DNA and antioxidant activity of ruthenium(II) complexes | Q39542878 | ||
| A potent trans-diimine platinum anticancer complex photoactivated by visible light. | Q39672784 | ||
| 27 Measurement of substrate and inhibitor binding to microsomal cytochrome P-450 by optical-difference spectroscopy | Q40161353 | ||
| A Red-Light-Activated Ruthenium-Caged NAMPT Inhibitor Remains Phototoxic in Hypoxic Cancer Cells. | Q41916219 | ||
| Optically selective two-photon uncaging of glutamate at 900 nm | Q42089850 | ||
| Caging the uncageable: using metal complex release for photochemical control over irreversible inhibition | Q42380738 | ||
| Eradication of Pathogenic Bacteria by Remote Delivery of Nitric Oxide via Light-Triggering of Nitrosyl-Containing Materials | Q42477170 | ||
| A caged nicotine with nanosecond range kinetics and visible light sensitivity | Q42913563 | ||
| Cellular toxicity induced by the photorelease of a caged bioactive molecule: design of a potential dual-action Ru(II) complex | Q43497813 | ||
| Photochemical or thermal chelate exchange in the ruthenium coordination sphere of complexes of the Ru(phen)(2)L family (L = diimine or dinitrile ligands). | Q43902694 | ||
| Direct near-infrared luminescence detection of singlet oxygen generated by photodynamic therapy in cells in vitro and tissues in vivo | Q43988000 | ||
| A new strategy for neurochemical photodelivery: metal-ligand heterolytic cleavage | Q44284606 | ||
| Reactions of NO with Mn(II) and Mn(III) centers coordinated to carboxamido nitrogen: synthesis of a manganese nitrosyl with photolabile NO. | Q44858713 | ||
| Photoinitiated DNA Binding by cis-[Ru(bpy)2(NH3)2]2+. | Q45141714 | ||
| Release of nitric oxide from a sol-gel hybrid material containing a photoactive manganese nitrosyl upon illumination with visible light | Q46041204 | ||
| Photodelivery of CO by designed PhotoCORMs: correlation between absorption in the visible region and metal-CO bond labilization in carbonyl complexes | Q46090471 | ||
| To cage or to be caged? The cytotoxic species in ruthenium-based photoactivated chemotherapy is not always the metal | Q46353606 | ||
| Near-infrared light activated release of nitric oxide from designed photoactive manganese nitrosyls: strategy, design, and potential as NO donors | Q46473759 | ||
| Mechanism of ligand photodissociation in photoactivable [Ru(bpy)2L2]2+ complexes: a density functional theory study | Q46512365 | ||
| Spontaneous formation in the dark, and visible light-induced cleavage, of a Ru-S bond in water: a thermodynamic and kinetic study | Q46622118 | ||
| Ruthenium(II) complexes of 1,12-diazaperylene and their interactions with DNA. | Q46647982 | ||
| Photoinduced CO release, cellular uptake and cytotoxicity of a tris(pyrazolyl)methane (tpm) manganese tricarbonyl complex | Q46671575 | ||
| Interaction of papain-like cysteine proteases with dipeptide-derived nitriles | Q46815936 | ||
| A new inorganic photolabile protecting group for highly efficient visible light GABA uncaging | Q46948586 | ||
| Combination of Ru(ii) complexes and light: new frontiers in cancer therapy | Q47108009 | ||
| N-substituted piperazinopyridylsteroid derivatives as abiraterone analogues inhibit growth and induce pro-apoptosis in human hormone-independent prostate cancer cell lines. | Q47883821 | ||
| Illuminating cytochrome P450 binding: Ru(ii)-caged inhibitors of CYP17A1. | Q48044713 | ||
| Ruthenium-containing P450 inhibitors for dual enzyme inhibition and DNA damage. | Q48313390 | ||
| N-Nmoc-L-glutamate, a new caged glutamate with high chemical stability and low pre-photolysis activity | Q48553864 | ||
| BODIPY-derived photoremovable protecting groups unmasked with green light | Q50438311 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1280-1290 | |
| P577 | publication date | 2018-01-11 | |
| P1433 | published in | Chemical Communications | Q426303 |
| P1476 | title | Ru(ii) polypyridyl complexes as photocages for bioactive compounds containing nitriles and aromatic heterocycles | |
| P478 | volume | 54 |
| Q89232651 | A Platinum(II) Complex of Heptamethine Cyanine for Photoenhanced Cytotoxicity and Cellular Imaging in Near-IR Light |
| Q90618948 | Designing Photolabile Ruthenium Polypyridyl Crosslinkers for Hydrogel Formation and Multiplexed, Visible-light Degradation |
| Q88612393 | New Ru(ii) complex for dual photochemotherapy: release of cathepsin K inhibitor and 1O2 production |
| Q57496070 | New Ru(ii) photocages operative with near-IR light: new platform for drug delivery in the PDT window |
| Q92945834 | Nitric Oxide Uncaging from a Hydrophobic Chromium(III) PhotoNORM: Visible and Near-Infrared Photochemistry in Biocompatible Polymer Disks |
| Q96765554 | Rationally designed ruthenium complexes for 1- and 2-photon photodynamic therapy |
| Q92980809 | Recent Advances on Octahedral Polypyridyl Ruthenium(II) Complexes as Antimicrobial Agents |
| Q55365212 | Ru(II) Polypyridyl Complexes Derived from Tetradentate Ancillary Ligands for Effective Photocaging. |
| Q99731949 | Ru(II)-diimine complexes and cytochrome P450 working hand-in-hand |
| Q58547514 | Ru(ii) complexes with diazine ligands: electronic modulation of the coordinating group is key to the design of "dual action" photoactivated agents |
Search more.